$269M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | DCTH Delcath Sys Inc | 3.3M | +0.0% | $42M | 15.4% |
| 2 | FENC Fennec Pharmaceuticals Inc | 3.2M | +9.6% | $34M | 12.7% |
| 3 | XERS Xeris Biopharma Holdings Inc | 2.9M | −10.0% | $23M | 8.6% |
| 4 | SVRA Savara Inc | 3.2M | −0.8% | $20M | 7.3% |
| 5 | VSTM Verastem Inc | 4.0M | +86.4% | $15M | 5.7% |
| 6 | XFOR X4 Pharmaceuticals Inc | 3.2M | +0.0% | $15M | 5.6% |
| 7 | EYPT Eyepoint Inc | 988,230 | −4.7% | $14M | 5.2% |
| 8 | HELP Cybin Inc | 2.0M | +27.7% | $13M | 4.8% |
| 9 | VOR Vor Biopharma Inc | 648,600 | −7.3% | $12M | 4.4% |
| 10 | PCVX Vaxcyte Inc | 200,000 | −31.0% | $12M | 4.3% |
| 11 | MDWD Mediwound Ltd | 749,054 | +0.0% | $11M | 4.1% |
| 12 | CLDX Celldex Therapeutics Inc New | 200,000 | −39.4% | $7M | 2.8% |
| 13 | BCRX Biocryst Pharmaceuticals Inc | 721,504 | −21.8% | $7M | 2.7% |
| 14 | PROF Profound Med Corp | 828,118 | +0.0% | $6M | 2.0% |
| 15 | TLPH Talphera Inc | 5.2M | +54.1% | $5M | 2.0% |
| 16 | AVIR Atea Pharmaceuticals Inc | 1.1M | −8.6% | $5M | 1.8% |
| 17 | MYO Myomo Inc | 3.6M | −5.4% | $4M | 1.4% |
| 18 | OVID Ovid Therapeutics Inc | 1.1M | +0.0% | $3M | 1.1% |
| 19 | NRXS Neuraxis Inc | 508,055 | +77.6% | $3M | 1.1% |
| 20 | ABVX Abivax Sa | 20,869 | — | $3M | 1.0% |
| 21 | NSPR Inspiremd Inc | 3.9M | +0.0% | $3M | 1.0% |
| 22 | RGNT Regentis Biomaterials Ltd | 701,685 | +179.0% | $2M | 0.9% |
| 23 | PYPD Polypid Ltd | 389,455 | −34.9% | $2M | 0.7% |
| 24 | BFRI Biofrontera Inc | 1.3M | +9.6% | $1M | 0.4% |
| 25 | KURA Kura Oncology Inc | 100,000 | +0.0% | $1M | 0.4% |
| 26 | SPRB Spruce Biosciences Inc | 20,000 | — | $1M | 0.4% |
| 27 | AQST Aquestive Therapeutics Inc | 250,000 | +0.0% | $1M | 0.4% |
| 28 | OKUR Onkure Therapeutics Inc | 150,000 | −66.2% | $684,000 | 0.3% |
| 29 | PEPG Pepgen Inc | 350,000 | — | $630,000 | 0.2% |